Merit Medical Systems, Inc. announced that its Embosphere microspheres are now indicated in the European Union for use in gen ...

The paper aims to increase awareness of cardiac long COVID and make management quicker, more accurate, and safer.

Novel research shows that in approximately one third of countries and territories worldwide, population aging was the largest ...

An artificial intelligence (AI) algorithm may allow clinicians to predict risk of keratoconus progression with more than 90% accuracy, according to a retrospective study.

Risks for developing Alzheimer’s disease can increase or decrease depending on when women begin hormone replacement therapy, ...

The Company has submitted a supplemental New Drug Application (sNDA) seeking the approval of revumenib for the treatment of R/R mNPM1 AML. The sNDA has been granted Priority Review by the FDA and ...

After 24 months, participants who received intensive periodontal treatment had significantly lower cIMT compared with the ...

Careful watching and follow up is also needed for patients with COVID-19, who should be told they are at an increased risk ...

AllRock Bio Inc., a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases, today announced a $50 million Series A round co-led by Versant ...

AllRock Bio secures $50 million to advance Roc-101, a promising treatment for pulmonary hypertension, aiming to transform patient care.